Anorexiants Market Insights: Latest Innovations in Appetite Suppressant Drugs
The global anorexiants market is poised for steady growth over the forecast period from 2024 to 2031, driven by a combination of increasing obesity rates, evolving dietary patterns, rising awareness around weight management, and supportive healthcare policies. The market, valued at approximately US$1 billion in 2024, is projected to expand at a compound annual growth rate (CAGR) of 5.3%, reaching an estimated US$1.43 billion by 2031. This growth trajectory highlights the critical role of anorexiants in addressing weight-related health challenges that are increasingly affecting populations worldwide.